I now have everything needed for a thorough, pedagogically structured answer. Here it is:
The Renin-Angiotensin-Aldosterone System (RAAS) - A Complete Pedagogical Guide
Overview: What is the RAAS?
The RAAS is a hormonal cascade that provides long-term regulation of arterial blood pressure (Pa), extracellular fluid (ECF) volume, and electrolyte homeostasis. Unlike the baroreceptor reflex (seconds), the RAAS operates over hours to days because it is hormonally - not neurally - mediated. As Guyton and Hall emphasize, the RAAS-kidney interaction is so powerful that "arterial pressure barely changes" across a 10-15x variation in daily salt intake when the system is fully operative. - Guyton and Hall Textbook of Medical Physiology
The Three-Organ Chain: Kidney → Lung/Kidney → Adrenal
The cascade links three anatomical sites. Teaching this geographically helps students remember it:
| Step | Organ | What happens |
|---|
| 1 | Kidney (JGA) | Renin secreted |
| 2 | Liver | Angiotensinogen is substrate |
| 3 | Lung/Kidney | ACE cleaves Ang I → Ang II |
| 4 | Adrenal cortex | Ang II triggers aldosterone release |
| 5 | Kidney tubules | Aldosterone acts on principal cells |
Step-by-Step Mechanism
Step 1 - The Trigger (What activates renin?)
Renin is stored in juxtaglomerular (JG) cells of afferent arterioles and released by four principal stimuli:
- Decreased renal perfusion pressure - sensed by stretch receptors in afferent arterioles (macula densa pathway)
- Decreased NaCl delivery to the macula densa of the distal convoluted tubule
- Sympathetic stimulation via β₁-adrenergic receptors on JG cells (e.g., hemorrhage, upright posture)
- Decreased plasma Na⁺ (rare - needs ~20 mEq/L drop)
Prorenin is constitutively produced; the active form is released by these stimuli. - Costanzo Physiology 7th Edition
Step 2 - Angiotensinogen → Angiotensin I
Renin is a protease enzyme (not a hormone). It cleaves angiotensinogen - an α-2 globulin made in the liver - by removing the N-terminal 10 amino acids to produce Angiotensin I (a decapeptide).
Angiotensin I has no meaningful biological activity - it is purely a precursor. - Tietz Textbook of Laboratory Medicine, 7th Edition
The amino acid chain at this stage:
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu
Step 3 - Angiotensin I → Angiotensin II (via ACE)
Angiotensin-converting enzyme (ACE), located predominantly in the lungs (also kidneys), cleaves the two C-terminal residues (His-Leu) from Angiotensin I to produce Angiotensin II - an octapeptide and the principal effector molecule of the RAAS.
Here is the peptide conversion pathway from Tietz Textbook of Laboratory Medicine:
Drug target: ACE inhibitors (captopril, enalapril) block this conversion step, eliminating all downstream Ang II effects.
Step 4 - Angiotensin II: The Master Effector
Angiotensin II acts at AT₁ receptors (Gq-coupled) in four key targets:
A. Adrenal Cortex (Zona Glomerulosa)
- Stimulates synthesis and secretion of aldosterone
- Requires gene transcription and new protein synthesis → hours to days for full effect
B. Kidney (Proximal Tubule)
- Directly stimulates Na⁺-H⁺ exchange, increasing Na⁺ and HCO₃⁻ reabsorption
- This is independent of aldosterone - a separate, faster renal effect
C. Hypothalamus / CNS
- Increases thirst and water intake
- Stimulates ADH (vasopressin) secretion → water reabsorption in collecting ducts
D. Arterioles
- Direct vasoconstriction via IP₃/Ca²⁺ second messenger → ↑ Total Peripheral Resistance (TPR) → ↑ Pa
The Costanzo flowchart captures all four arms beautifully:
Fig. 4.33 from Costanzo Physiology 7th Edition - the system described in terms of the response to a decrease in Pa. ECF = extracellular fluid; TPR = total peripheral resistance.
Step 5 - Aldosterone: The Final Effector
Aldosterone is a mineralocorticoid steroid from the zona glomerulosa of the adrenal cortex. It acts on principal cells of the distal tubule and collecting duct:
- Upregulates ENaC (epithelial Na⁺ channels on apical membrane) - increases Na⁺ entry
- Upregulates Na⁺/K⁺-ATPase on basolateral membrane - pumps Na⁺ out into blood
- K⁺ and H⁺ are secreted in exchange (explains hypokalemia and alkalosis in hyperaldosteronism)
- Net effect: Na⁺ and water retention → ↑ ECF volume → ↑ blood volume → ↑ Pa
The mechanism requires new protein synthesis, which accounts for the slow time course of this arm. - Costanzo Physiology 7th Edition
Other stimuli for aldosterone release (not via renin):
- Elevated plasma K⁺ (very sensitive - only 1 mEq/L increase is enough)
- ACTH (minor, permissive role)
- These two stimuli are important: they explain why aldosterone can be regulated separately from the RAAS axis. - Ganong's Review of Medical Physiology, 26th Edition
The Negative Feedback Loop
The Ganong feedback diagram:
Figure 19-22 from Ganong's Review of Medical Physiology - feedback mechanism regulating aldosterone secretion. The dashed arrow indicates inhibition.
The feedback loop:
- ↓ ECF volume → ↑ Renin → ↑ Ang II → ↑ Aldosterone
- Aldosterone → ↓ Na⁺/water excretion → ↑ ECF volume
- ↑ ECF volume → ↑ renal arterial pressure + ↓ renal nerve discharge → inhibits renin secretion (negative feedback, dashed line)
There is also a proposed "short-loop" feedback: Ang II may directly inhibit renin secretion via AT₁ receptors on JG cells, though this is not conclusively proven. - Tietz Textbook of Laboratory Medicine
Pedagogical Summary Table
| Component | Source | Role | Drug target |
|---|
| Renin | Kidney JGA | Cleaves angiotensinogen | β-blockers ↓ renin; direct renin inhibitors (aliskiren) |
| Angiotensinogen | Liver | Substrate | - |
| Angiotensin I | Plasma | Inactive precursor | - |
| ACE | Lungs/Kidneys | Converts Ang I → Ang II | ACE inhibitors (captopril, enalapril) |
| Angiotensin II | Plasma/Tissues | Vasoconstriction, thirst, ADH, aldosterone | ARBs (losartan, valsartan) |
| Aldosterone | Adrenal zona glomerulosa | Na⁺/water retention, K⁺ excretion | Spironolactone, eplerenone (MR antagonists) |
Clinical Applications (Pedagogical Anchors)
1. Renal artery stenosis - The ischemic kidney hypersecrets renin → Ang II drives up BP. Plasma renin activity is elevated, and renin levels are much higher in the affected renal vein. Treatment: ACE inhibitor (captopril). - Costanzo Physiology 7th Edition, Box 4.2
2. Heart failure - Reduced cardiac output → ↓ renal perfusion → RAAS activation → Na⁺/water retention → worsening preload and afterload. ACE inhibitors and ARBs are cornerstone therapies precisely because they break this vicious cycle.
3. Primary hyperaldosteronism (Conn syndrome) - Aldosterone-secreting adrenal adenoma produces aldosterone independently of renin. The exact mechanism by which adrenal tumors acquire autonomy from the RAAS is not completely understood. Clinically: hypertension + hypokalemia + suppressed renin. - Tietz Textbook of Laboratory Medicine
4. Dietary sodium restriction - Reduces ECF volume → reflexive increase in renal nerve activity → ↑ Renin (before any fall in BP). Salt depletion also upregulates AT₁ receptors in the adrenal cortex and downregulates them in blood vessels, amplifying the aldosterone response but blunting vasoconstriction. - Ganong's Review of Medical Physiology
5. Drug interactions - ACE inhibitors also block bradykinin breakdown (bradykinin is another ACE substrate), causing the well-known ACE inhibitor cough. ARBs do not block ACE, so they don't cause this side effect.
RAAS vs. Baroreceptor Reflex - Teaching Contrast
| Feature | Baroreceptor Reflex | RAAS |
|---|
| Speed | Seconds | Hours to days |
| Mechanism | Neural | Hormonal |
| Primary effector | Heart rate, TPR | Na⁺ retention, ECF volume |
| Restoration | Partial | Near-complete (nearly infinite feedback gain for long-term Pa) |
| Dysregulation | Minimal long-term impact | Hypertension, HF, CKD |
Teaching Video
This animated RAAS overview from Alila Medical Media is excellent for visual learners (1 million+ views):
Sources: Costanzo Physiology 7th Edition | Guyton and Hall Textbook of Medical Physiology | Ganong's Review of Medical Physiology, 26th Edition | Tietz Textbook of Laboratory Medicine, 7th Edition |
StatPearls - Physiology, Renin Angiotensin System